2026 Annual Meeting | S22 - Neuroinfectious Disease: Basic Sciences
Program Materials Program Evaluations
| George Eng, MD, PhD | Dr. Eng has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DelveBio. |
| Linzy Rosen | Ms. Rosen has nothing to disclose. |
| Steve Miller, MD, PhD | Dr. Miller has received personal compensation for serving as an employee of Delve Bio. |
| XIAOHONG WU, MD, PhD | Dr. WU has nothing to disclose. |
| Huei-Yu F. Wang, PhD | Dr. Wang has received personal compensation for serving as an employee of Delve BIo. |
| Christopher H. Gibbons, MD, FAAN | Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care. |
| Zeynep Agirman | Ms. Agirman has nothing to disclose. |
| Hemi Park, MPH | Ms. Park has nothing to disclose. |
| Ben Bradley, MD, PhD | Dr. Bradley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. |
| Kunling Wu | Ms. Wu has nothing to disclose. |
| Dante G. Minichetti | Miss Minichetti has nothing to disclose. |
| Keely Copperthite | Ms. Copperthite has nothing to disclose. |
| Donald Franklin, Jr., Research Administrator | Mr. Franklin has nothing to disclose. |
| Omer Milstein | Mr. Milstein has nothing to disclose. |
| Emily Hyle, MD | The institution of Dr. Hyle has received research support from NIH. The institution of Dr. Hyle has received research support from MGH. Dr. Hyle has received publishing royalties from a publication relating to health care. |
| Jacqueline Koble | Ms. Koble has nothing to disclose. |
| Michael R. Wilson, MD, FAAN | Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ouro Medicines. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Indapta Therapeutics. Dr. Wilson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dunham Hallmark. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. The institution of Dr. Wilson has received research support from Kyverna Therapeutics. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice. |
| Khushbu Patel, MD | Dr. Patel has nothing to disclose. |
| Marina Avetisyan, MD, PhD | Dr. Avetisyan has nothing to disclose. |
| Rohan Bhukar, MS | Mr. Bhukar has nothing to disclose. |
| Monica M. Diaz, MD, MS | The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund. |
| Leah H. Rubin, PhD | Dr. Rubin has nothing to disclose. |
| Sasha Gupta, MD | Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend . Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Lora Bankova, MD | Dr. Bankova has nothing to disclose. |
| Jamison Burks, PhD | Dr. Burks has nothing to disclose. |
| Bailey Bellaire | Bailey Bellaire has received personal compensation for serving as an employee of CND Life Sciences. |
| Petra Bachanova | Miss Bachanova has received personal compensation for serving as an employee of Dartmouth College. |
| Mark W. Albers, MD, PhD | An immediate family member of Dr. Albers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Aromha. Dr. Albers has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Aromha. Dr. Albers has stock in Berkshire Hathaway. Dr. Albers has stock in Curis. The institution of Dr. Albers has received research support from NIH. Dr. Albers has received intellectual property interests from a discovery or technology relating to health care. |
| Sikha Sinha, PhD | Dr. Sinha has nothing to disclose. |
| Matthew Harris | Matthew Harris has nothing to disclose. |
| Sudeb Dalai, MD, PhD | Dr. Dalai has received personal compensation for serving as an employee of Delve Bio. |
| Marleny Nolasco | Marleny Nolasco has nothing to disclose. |
| Jose F. Camargo | No disclosure on file |
| Sirisha Thippabhotla, PhD | Ms. Thippabhotla has nothing to disclose. |
| Sumanth Reddy, MD | Dr. Reddy has nothing to disclose. |
| Beyzanur Ergun, MD | Dr. Ergun has nothing to disclose. |
| Kimberly Hanson, MD | Dr. Hanson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karius. Dr. Hanson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Delve Bio. Dr. Hanson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IDSA/CID. Dr. Hanson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASM/JCM. Dr. Hanson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UptoDate. The institution of Dr. Hanson has received research support from ARLG/NIH. |
| Anna Uehara, PhD | Dr. Uehara has received personal compensation for serving as an employee of Delve Bio. An immediate family member of Dr. Uehara has received personal compensation for serving as an employee of Clear Labs. |
| Sarrah Marcotte | Miss Marcotte has received personal compensation for serving as an employee of CND Life Sciences. |
| Pia Kivisakk Webb, MD, PhD | Dr. Kivisakk Webb has nothing to disclose. |
| Jordan Jimenez | Ms. Jimenez has nothing to disclose. |
| Kayli Liles | Ms. Liles has nothing to disclose. |
| Manuel X. Duval, PhD | Mr. Duval has received personal compensation for serving as an employee of CND Life sciences. |
| Daniel V. De Siqueira Lima, Jr., MD | Dr. De Siqueira Lima has nothing to disclose. |
| Ryan Norville | Mr. Norville has received personal compensation for serving as an employee of Delve Bio. |
| Katherine Tassiopoulos, DSc | Dr. Tassiopoulos has nothing to disclose. |
| Robert W. Parker III, PharmD | Dr. Parker has nothing to disclose. |
| Timothy Blicharz, PhD | Dr. Blicharz has received personal compensation for serving as an employee of Delve Bio, Inc. Dr. Blicharz has received personal compensation for serving as an employee of Sherlock Biosciences. Dr. Blicharz has received personal compensation for serving as an employee of LumiraDx. Dr. Blicharz has stock in Delve Bio, Inc. Dr. Blicharz has stock in YourBio Health. Dr. Blicharz has received intellectual property interests from a discovery or technology relating to health care. |
| Patricia K. Riggs, DO | Dr. Riggs has nothing to disclose. |
| Prajakta A. Pradhan, MS | Mrs. Pradhan has nothing to disclose. |
| Scott L. Letendre, MD | The institution of Dr. Letendre has received research support from National Institutes of Health. The institution of Dr. Letendre has received research support from University at Buffalo. Dr. Letendre has received publishing royalties from a publication relating to health care. |
| Kevin L. Park, MD | Dr. Park has nothing to disclose. |
| Yair Mina, MD | Dr. Mina has nothing to disclose. |
| Samiksha Patil, DO | Ms. Patil has nothing to disclose. |
| Ronald J. Ellis, MD, PhD, FAAN | Dr. Ellis has nothing to disclose. |
| Eric H. Holbrook, MD | Dr. Holbrook has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rhino Therapeutics. Dr. Holbrook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axiom Labs. The institution of Dr. Holbrook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lyra. Dr. Holbrook has stock in Rhino Therapeutics. Dr. Holbrook has stock in Axiom Labs. Dr. Holbrook has received publishing royalties from a publication relating to health care. |
| Anthony Leung | No disclosure on file |
| Elena Beideck, MD | Dr. Beideck has nothing to disclose. |
| Eran Dayan | The institution of Dr. Dayan has received research support from National Institutes of Health. The institution of Dr. Dayan has received research support from National Institutes of Health. |
| Benjamin Smarr, PhD | Prof. Smarr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ouraring Inc. Prof. Smarr has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INTO Inc. Prof. Smarr has stock in Ouraring Inc. The institution of Prof. Smarr has received research support from DoD/MTEC. The institution of Prof. Smarr has received research support from Intel Inc. |
| Roy L. Freeman, MD | Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron. |
| Alefiya D. Albers, PhD | Dr. Albers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AROMHA, Inc. An immediate family member of Dr. Albers has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Aromha, Inc. An immediate family member of Dr. Albers has stock in Berkshire Hathaway. An immediate family member of Dr. Albers has stock in Curis. The institution of an immediate family member of Dr. Albers has received research support from NIH. An immediate family member of Dr. Albers has received intellectual property interests from a discovery or technology relating to health care. |
| Nhien Nguyen | Ms. Nguyen has nothing to disclose. |
| Mohammed Raja, MD | Dr. Raja has nothing to disclose. |
| Jourdan Parent, PhD | Dr. Parent has received personal compensation for serving as an employee of CND Life Sciences. |
| Colin Magdamo, BS | Mr. Magdamo has received research support from NIH. Mr. Magdamo has received intellectual property interests from a discovery or technology relating to health care. |
| Raghav Tirupathi | No disclosure on file |
| Felicia Chow, MD | Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medicolegal consulting. The institution of Dr. Chow has received research support from NIH. |
| Aakash D. Patil | Mr. Patil has nothing to disclose. |
| Todd D. Levine, MD | Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab. |
| Shibani S. Mukerji, MD, PhD | Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital. |
| HaeWon Shin, MD | The institution of Dr. Shin has received research support from NIH RO1. The institution of Dr. Shin has received research support from NIH U Grant. The institution of Dr. Shin has received research support from UCB. The institution of Dr. Shin has received research support from Biogen. The institution of Dr. Shin has received research support from Neuropace. The institution of Dr. Shin has received research support from Praxis Precision Medicine. |
| Hengbin Zhang, RN | Mr. Zhang has nothing to disclose. |
| Renzo J. Villanueva Villegas, Sr., MD | Dr. Villanueva Villegas has nothing to disclose. |
| Emily Crawford, PhD | Dr. Crawford has received personal compensation for serving as an employee of Delve Bio. |
| Steven M. Phillips, DO | Dr. Phillips has nothing to disclose. |
| Mattia Trunfio, MD, PhD | Dr. Trunfio has nothing to disclose. |